{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:18:14Z","timestamp":1787818694646,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Radiol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00256-026-05284-2","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:25:37Z","timestamp":1782804337000},"page":"2613-2625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MRI-Based radiomic signature for predicting pathologic treatment response to neoadjuvant chemoradiotherapy and radioimmunotherapy in soft tissue sarcoma"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-1593","authenticated-orcid":false,"given":"Majid","family":"Chalian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefe","family":"Pooyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Haseli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoozeh","family":"Shomal Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chankue","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Mantilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin D.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie K.","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee D.","family":"Cranmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Kinahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Nyflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"12","key":"5284_CR1","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s41591-018-0255-8","volume":"24","author":"F Bensch","year":"2018","unstructured":"Bensch F, van der Veen EL, Lub-de Hooge MN, Jorritsma-Smit A, Boellaard R, Kok IC, et al. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nat Med. 2018;24(12):1852\u20138.","journal-title":"Nat Med"},{"key":"5284_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14293","volume":"8","author":"MF Cuccarese","year":"2017","unstructured":"Cuccarese MF, Dubach JM, Pfirschke C, Engblom C, Garris C, Miller MA, et al. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat Commun. 2017;8:14293.","journal-title":"Nat Commun"},{"issue":"2","key":"5284_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","volume":"113","author":"M Sbaraglia","year":"2020","unstructured":"Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica. 2020;113(2):70\u201384.","journal-title":"Pathologica"},{"issue":"10","key":"5284_CR4","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1038\/bjc.2014.200","volume":"110","author":"C Rothermundt","year":"2014","unstructured":"Rothermundt C, Whelan JS, Dileo P, Strauss SJ, Coleman J, Briggs TW, et al. What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer. 2014;110(10):2420\u20136.","journal-title":"Br J Cancer"},{"issue":"Suppl 1","key":"5284_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3747\/co.27.5407","volume":"27","author":"O Ayodele","year":"2020","unstructured":"Ayodele O, Razak ARA. Immunotherapy in soft-tissue sarcoma. Curr Oncol (Tor Ont). 2020;27(Suppl 1):17\u201323.","journal-title":"Curr Oncol (Tor Ont)"},{"key":"5284_CR6","doi-asserted-by":"publisher","first-page":"4508794","DOI":"10.1155\/2019\/4508794","volume":"2019","author":"M Sambi","year":"2019","unstructured":"Sambi M, Bagheri L, Szewczuk MR. Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates. J Oncol. 2019;2019:4508794.","journal-title":"J Oncol"},{"issue":"3","key":"5284_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/SLA.0b013e3181cf87fa","volume":"251","author":"A Gronchi","year":"2010","unstructured":"Gronchi A, Lo Vullo S, Colombo C, Collini P, Stacchiotti S, Mariani L, et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg. 2010Mar;251(3):506\u201311.","journal-title":"Ann Surg"},{"key":"5284_CR8","doi-asserted-by":"publisher","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2016;278(2):563\u201377.\u00a0https:\/\/doi.org\/10.1148\/radiol.2015151169. Epub 2015 Nov 18. PMID: 26579733; PMCID: PMC4734157.","DOI":"10.1148\/radiol.2015151169"},{"key":"5284_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ebiom.2019.08.059","volume":"48","author":"JC Peeken","year":"2019","unstructured":"Peeken JC, Spraker MB, Knebel C, Dapper H, Pfeiffer D, Devecka M, et al. Tumor grading of soft tissue sarcomas using MRI-based radiomics. EBioMedicine. 2019;48:332\u201340.","journal-title":"EBioMedicine"},{"issue":"91","key":"5284_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mri.2022.05.003","volume":"1","author":"Z Yue","year":"2022","unstructured":"Yue Z, Wang X, Yu T, Shang S, Liu G, Jing W, et al. Multi-parametric MRI-based radiomics for the diagnosis of malignant soft-tissue tumor. Magn Reson Imaging. 2022;1(91):91\u20139.","journal-title":"Magn Reson Imaging"},{"issue":"11","key":"5284_CR11","doi-asserted-by":"publisher","first-page":"8522","DOI":"10.1007\/s00330-021-07914-w","volume":"31","author":"BKK Fields","year":"2021","unstructured":"Fields BKK, Demirjian NL, Hwang DH, Varghese BA, Cen SY, Lei X, et al. Whole-tumor 3D volumetric MRI-based radiomics approach for distinguishing between benign and malignant soft tissue tumors. Eur Radiol. 2021;31(11):8522\u201335.","journal-title":"Eur Radiol"},{"issue":"2","key":"5284_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.adro.2019.02.003","volume":"4","author":"MB Spraker","year":"2019","unstructured":"Spraker MB, Wootton LS, Hippe DS, Ball KC, Peeken JC, Macomber MW, et al. MRI radiomic features are independently associated with overall survival in soft tissue sarcoma. Adv Radiat Oncol. 2019;4(2):413\u201321.","journal-title":"Adv Radiat Oncol"},{"key":"5284_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.radonc.2019.01.004","volume":"135","author":"JC Peeken","year":"2019","unstructured":"Peeken JC, Bernhofer M, Spraker MB, Pfeiffer D, Devecka M, Thamer A, et al. CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy. Radiother Oncol. 2019;135:187\u201396.","journal-title":"Radiother Oncol"},{"key":"5284_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.710649","volume":"11","author":"S Chen","year":"2021","unstructured":"Chen S, Li N, Tang Y, Chen B, Fang H, Qi S, et al. Radiomics analysis of fat-saturated T2-weighted MRI sequences for the prediction of prognosis in soft tissue sarcoma of the extremities and trunk treated with neoadjuvant radiotherapy. Front Oncol. 2021;11:710649.","journal-title":"Front Oncol"},{"issue":"8","key":"5284_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081929","volume":"13","author":"JC Peeken","year":"1929","unstructured":"Peeken JC, Neumann J, Asadpour R, Leonhardt Y, Moreira JR, Hippe DS, et al. Prognostic assessment in high-grade soft-tissue sarcoma patients: a comparison of semantic image analysis and radiomics. Cancers. 1929;13(8):1929.","journal-title":"Cancers"},{"key":"5284_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.radonc.2021.08.023","volume":"164","author":"JC Peeken","year":"2021","unstructured":"Peeken JC, Asadpour R, Specht K, Chen EY, Klymenko O, Akinkuoroye V, et al. MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy. Radiother Oncol. 2021;164:73\u201382.","journal-title":"Radiother Oncol"},{"issue":"2","key":"5284_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jmri.26589","volume":"50","author":"A Cromb\u00e9","year":"2019","unstructured":"Cromb\u00e9 A, P\u00e9rier C, Kind M, De Senneville BD, Le Loarer F, Italiano A, et al. T2-based MRI delta-radiomics improve response prediction in soft-tissue sarcomas treated by neoadjuvant chemotherapy. J Magn Reson Imaging. 2019;50(2):497\u2013510.","journal-title":"J Magn Reson Imaging"},{"key":"5284_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109283","volume":"132","author":"A Cromb\u00e9","year":"2020","unstructured":"Cromb\u00e9 A, Fadli D, Italiano A, Saut O, Buy X, Kind M. Systematic review of sarcomas radiomics studies: bridging the gap between concepts and clinical applications? Eur J Radiol. 2020;132:109283.","journal-title":"Eur J Radiol"},{"key":"5284_CR19","doi-asserted-by":"publisher","unstructured":"Mongan J, Moy L, Kahn CE Jr. Checklist for artificial intelligence in medical imaging (CLAIM): A guide for authors and reviewers.\u00a0Radiol Artif Intel. 2020;2(2):e200029. https:\/\/doi.org\/10.1148\/ryai.2020200029.","DOI":"10.1148\/ryai.2020200029"},{"issue":"21","key":"5284_CR20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJ van Griethuysen","year":"2017","unstructured":"van Griethuysen JJ, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017Nov 1;77(21):e104.","journal-title":"Cancer Res"},{"issue":"2","key":"5284_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1148\/radiol.2512081403","volume":"251","author":"S Stacchiotti","year":"2009","unstructured":"Stacchiotti S, Collini P, Messina A, Morosi C, Barisella M, Bertulli R, et al. High-grade soft-tissue sarcomas: tumor response assessment\u2014pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology. 2009;251(2):447\u201356.","journal-title":"Radiology"},{"key":"#cr-split#-5284_CR22.1","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C (2016) XGBoost: a scalable tree boosting system [Internet]. arXiv","DOI":"10.1145\/2939672.2939785"},{"key":"#cr-split#-5284_CR22.2","unstructured":"[cited 2024 Nov 5]. Available from: http:\/\/arxiv.org\/abs\/1603.02754"},{"key":"5284_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2018.05.007","volume":"69","author":"S Salah","year":"2018","unstructured":"Salah S, Lewin J, Amir E, Abdul RA. Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: a systematic review and meta-analysis. Cancer Treat Rev. 2018Sep;69:1\u201310.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5284_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/cam4.4428","volume":"11","author":"SR Rao","year":"2022","unstructured":"Rao SR, Lazarides AL, Leckey BL, Lane WO, Visgauss JD, Somarelli JA, et al. Extent of tumor fibrosis\/hyalinization and infarction following neoadjuvant radiation therapy is associated with improved survival in patients with soft-tissue sarcoma. Cancer Med. 2022;11(1):194\u2013206.","journal-title":"Cancer Med"},{"issue":"2","key":"5284_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"23","key":"5284_CR26","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1002\/cncr.27624","volume":"118","author":"S Stacchiotti","year":"2012","unstructured":"Stacchiotti S, Verderio P, Messina A, Morosi C, Collini P, Llombart-Bosch A, et al. Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer. 2012;118(23):5857\u201366.","journal-title":"Cancer"},{"issue":"7","key":"5284_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41416-019-0558-7","volume":"121","author":"MP Solis-Hernandez","year":"2019","unstructured":"Solis-Hernandez MP, Fernandez del Valle A, Carmona-Bayonas A, Garcia-Carbonero R, Custodio A, Benavent M, et al. Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study). Br J Cancer. 2019;121(7):537\u201344.","journal-title":"Br J Cancer"},{"key":"5284_CR28","doi-asserted-by":"publisher","unstructured":"Cromb\u00e9 A, Spinnato P, Italiano A, Brisse HJ, Feydy A, Fadli D, Kind M. Radiomics and artifi cial intelligence for soft-tissue sarcomas: Current status and perspectives. Diagn Interv Imaging. 2023;104(12):567\u2013583 https:\/\/doi.org\/10.1016\/j.diii.2023.09.005. Epub 2023 Oct 4. PMID: 37802753.","DOI":"10.1016\/j.diii.2023.09.005"},{"key":"5284_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-021-01008-3","author":"S Gitto","year":"2021","unstructured":"Gitto S, Cuocolo R, Albano D. CT and MRI radiomics of bone and soft-tissue sarcomas: a systematic review of reproducibility and validation strategies. Insights Imaging. 2021. https:\/\/doi.org\/10.1186\/s13244-021-01008-3.","journal-title":"Insights Imaging"},{"issue":"1","key":"5284_CR30","first-page":"1","volume":"8","author":"A Cromb\u00e9","year":"2024","unstructured":"Cromb\u00e9 A, Lucchesi C, Bertolo F, Kind M, Spalato-Ceruso M, Toulmonde M, et al. Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis. Npj Precis Oncol. 2024;8(1):1\u201313.","journal-title":"Npj Precis Oncol"},{"issue":"17","key":"5284_CR31","doi-asserted-by":"publisher","first-page":"175006","DOI":"10.1088\/1361-6560\/ab9e58","volume":"65","author":"Y Gao","year":"2020","unstructured":"Gao Y, Kalbasi A, Hsu W, Ruan D, Fu J, Shao J, et al. Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs. Phys Med Biol. 2020;65(17):175006.","journal-title":"Phys Med Biol"},{"issue":"4","key":"5284_CR32","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s11307-023-01803-y","volume":"25","author":"BKK Fields","year":"2023","unstructured":"Fields BKK, Demirjian NL, Cen SY, Varghese BA, Hwang DH, Lei X, et al. Predicting soft tissue sarcoma response to neoadjuvant chemotherapy using an MRI-based delta-radiomics approach. Mol Imaging Biol. 2023;25(4):776\u201387.","journal-title":"Mol Imaging Biol"},{"issue":"8","key":"5284_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00247-004-1192-x","volume":"34","author":"H Brisse","year":"2004","unstructured":"Brisse H, Ollivier L, Edeline V, Pacquement H, Michon J, Glorion C, et al. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment. Pediatr Radiol. 2004;34(8):595\u2013605.","journal-title":"Pediatr Radiol"},{"issue":"11","key":"5284_CR34","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(17)30624-1","volume":"18","author":"HA Tawbi","year":"2017","unstructured":"Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, et al. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017;18(11):1493\u2013501.","journal-title":"Lancet Oncol"},{"issue":"15_suppl","key":"5284_CR35","doi-asserted-by":"publisher","first-page":"11015","DOI":"10.1200\/JCO.2019.37.15_suppl.11015","volume":"37","author":"MA Burgess","year":"2019","unstructured":"Burgess MA, Bolejack V, Schuetze S, Van Tine BA, Attia S, Riedel RF, et al. Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated\/pleomorphic liposarcoma (LPS): final results of SARC028 expansion cohorts. J Clin Oncol. 2019;37(15_suppl):11015\u201311015.","journal-title":"J Clin Oncol"}],"container-title":["Skeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-026-05284-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00256-026-05284-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-026-05284-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:36:46Z","timestamp":1787816206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00256-026-05284-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5284"],"URL":"https:\/\/doi.org\/10.1007\/s00256-026-05284-2","relation":{},"ISSN":["0364-2348","1432-2161"],"issn-type":[{"value":"0364-2348","type":"print"},{"value":"1432-2161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received approval from our institutional review board (IRB#STUDY00011377). A waiver of informed consent was granted for the use of retrospective, anonymized patient data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}